Physician

Keith David Aaronson, MD

According to 2025 Medicare claims, Keith Aaronson, MD (NPI: 1144305301) practices advanced heart failure and transplant cardiology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is REGENTS OF THE UNIVERSITY OF MICHIGAN (NPI: 1891205969; TIN: 386006309) and primary practice location at 48109-5000. Aaronson is affiliated with the POM ACO (ACO ID: A1297), Mosaic ACO (ACO ID: A5033), Aledade 155 National MSSP (ACO ID: A5358), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Aaronson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 117 traditional Medicare patients, billed 309 HCPCS/CPT codes, and received $23,772 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,728 prescription claims across 170 beneficiaries totaling $840,257 in drug costs, led by Vyndamax (Tafamidis). DME data shows 419 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $49,841 to $23,772. In contrast, Part D prescription costs have moved sharply higher in recent years, from $220,552 to $840,257. For DME billing, this smaller-volume category fell sharply in recent years, from $4,839 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	230	838	$49,841
2016	270	916	$60,637
2017	234	860	$59,518
2018	285	1,050	$76,020
2019	236	795	$70,540
2020	201	568	$47,058
2021	172	575	$55,609
2022	161	408	$42,082
2023	132	307	$25,823
2024	117	309	$23,772

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	164	2,457	$220,552
2016	176	2,520	$230,265
2017	184	2,837	$298,861
2018	194	2,991	$293,104
2019	188	2,690	$285,402
2020	176	2,584	$310,615
2021	163	2,338	$339,605
2022	153	2,400	$637,416
2023	163	2,642	$836,526
2024	170	2,728	$840,257

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	63	673	$40,139
2016	64	739	$129,860
2017	63	824	$116,511
2018	73	840	$86,636
2019	55	890	$109,900
2020	40	680	$85,978
2021	26	505	$31,371
2022	23	463	$30,004
2023	26	527	$32,135
2024	26	419	$16,924

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	39	41	$104
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	20	49	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	49	54	$70
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	17	38	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	47	50	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	12	360	$278,512
Entresto	Sacubitril/Valsartan	117	8,647	$188,714
Jardiance	Empagliflozin	85	6,450	$124,718
Eliquis	Apixaban	87	4,620	$87,046
Farxiga	Dapagliflozin Propanediol	29	2,444	$42,122

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	27	$9,622
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	14	127	$2,170
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	12	71	$1,299
J7520	Sirolimus, oral, 1 mg	N	N/R	33	$1,272
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	62	$1,186

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Keith David Aaronson, MD?

Tedicare shows public-source Medicare data for Keith David Aaronson, MD (NPI 1144305301), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Keith David Aaronson, MD have ACO affiliation data?

Keith David Aaronson, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), Mosaic ACO (MSSP, ACO ID A5033), Aledade 155 National MSSP (MSSP, ACO ID A5358), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Keith David Aaronson, MD?

Keith David Aaronson, MD is linked to REGENTS OF THE UNIVERSITY OF MICHIGAN (billing NPI 1891205969) in the available physician profile data.

Does Keith David Aaronson, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.